Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Paraganglioma × Everolimus × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 2 Tuberous Sclerosis Complex-associated Refractory Seizures 1 Kidney Neoplasms 1

Interventions

lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 belzutifan 1 Lutetium-177 1 Lutetium 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡